This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for ▼Besponsa® (inotuzumab ozogamicin) Great Britain (GB) and Northern Ireland (NI)​​​​​​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Besponsa (inotuzumab ozogamicin) 1mg powder - PI for GB

Northern Ireland

  • Besponsa (inotuzumab ozogamicin) 1mg - PI for NI

Besponsa (inotuzumab ozogamicin) 1mg powder - PI for GB

Besponsa (inotuzumab ozogamicin) 1mg - PI for NI

PP-INO-GBR-0867 October 2023